Finally, upregulation of SMN upon activation of phosphatidylinositol 3-kinase (PI3K)/AKT and its positive impact on disease phenotype of severe SMA has been demonstrated60. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.